Filing Details
- Accession Number:
- 0001104659-22-127961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-16 17:59:16
- Reporting Period:
- 2022-12-14
- Accepted Time:
- 2022-12-16 17:59:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711933 | Akoya Biosciences Inc. | AKYA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1392297 | Joseph Driscoll | 100 Campus Drive,6Th Floor Marlborough MA 01762 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-14 | 10,039 | $0.44 | 22,539 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-14 | 10,039 | $12.67 | 12,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-14 | 14,574 | $0.44 | 27,074 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-14 | 14,574 | $12.46 | 12,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2022-12-14 | 10,039 | $0.00 | 10,039 | $0.44 |
| Common Stock | Employee Stock Option (Right to Buy | Disposition | 2022-12-14 | 14,574 | $0.00 | 14,574 | $0.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 123,466 | 2029-05-02 | No | 4 | M | Direct | |
| 108,712 | 2029-05-02 | No | 4 | M | Direct |
Footnotes
- Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.60 - $12.80. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.
- Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.40 - $12.615. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.
- Such performance-based option shares were issued in 2019. In 2020, the options vested as performance conditions were determined to have been achieved.
Billionaire Hedge Funds
